High dose hypofractionated proton beam therapy is a safe and feasible treatment for central lung cancer
Language: English
Page range: 324 - 330
Submitted on: Jan 17, 2017
|Accepted on: May 14, 2017
|Published on: Jun 16, 2017
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2017 Takashi Ono, Tomonori Yabuuchi, Tatsuya Nakamura, Kanako Kimura, Yusuke Azami, Katsumi Hirose, Motohisa Suzuki, Hitoshi Wada, Yasuhiro Kikuchi, Kenji Nemoto, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution 4.0 License.